Inogen, Inc (INGN) News

Inogen, Inc (INGN): $22.85

0.07 (+0.31%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter INGN News Items

INGN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

INGN News Highlights

  • For INGN, its 30 day story count is now at 9.
  • Over the past 7 days, the trend for INGN's stories per day has been choppy and unclear. It has oscillated between 1 and 6.

Latest INGN News From Around the Web

Below are the latest news stories about INOGEN INC that investors may wish to consider to help them evaluate INGN as an investment opportunity.

INGN stock lower as William Blair downgrades on macro headwinds (NASDAQ:INGN)

The shares of Inogen Inc. (INGN) fell in the morning hours Tuesday after William Blair downgraded it to Market Perform from Outperform, citing macro headwinds. Read the full story here.

Seeking Alpha | January 17, 2023

Inogen (INGN) Announces Solid Preliminary Q4 Revenues

Inogen's (INGN) revenue growth in the fourth quarter is likely to have been boosted by continued strength in its product sales.

Yahoo | January 13, 2023

Inogen Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Within Company Expectations

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced unaudited preliminary revenue results for the fourth quarter and the full year ended December 31, 2022. The Company estimates preliminary, unaudited total revenue in the fourth quarter of 2022 to be in the range of $87.5 million to $88.5 million, representing year-over-year growth of 14.5% to 15.8%. Full year 2022 to

Business Wire | January 10, 2023

Inogen

Inogen (INGN) estimates Q4 total revenue to be in the range of $87.5M to $88.5M, representing Y/Y growth of 14.5% to 15.8%, vs consensus of $89.48M

Seeking Alpha | January 10, 2023

Inogen Achieves Regulatory Milestones to Support Current and Future Products

GOLETA, Calif., January 10, 2023--Inogen Achieves Regulatory Milestones to Support Current and Future Products

Yahoo | January 10, 2023

3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio

Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.

Yahoo | December 27, 2022

Inogen to Present at 41st Annual J.P. Morgan Healthcare Conference

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference. Nabil Shabshab, President and Chief Executive Officer, is scheduled to present on Wednesday, January 11, 2023, at 10:30 a.m. Pacific Time. A

Wallstreet:Online | December 13, 2022

Why Is Shockwave Medical (SWAV) Down 8.3% Since Last Earnings Report?

Shockwave Medical (SWAV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 7, 2022

Inogen (INGN): No Change To Thesis, Similar Theme In Q3 Numbers

Structural, supply chain headwinds remain in situ, especially compressing divisional sales growth in Q3. Click here to read my analysis of Inogen stock.

Seeking Alpha | December 2, 2022

Inogen to Present at Upcoming Investor Conferences in November 2022

GOLETA, Calif.--(BUSINESS WIRE)--Inogen to Present at Upcoming Investor Conferences in November 2022

Business Wire | November 3, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7023 seconds.